CEREBELLUM DYSPLASTIC GANGLIOCYTOMA

Clinical trials for CEREBELLUM DYSPLASTIC GANGLIOCYTOMA explained in plain language.

Never miss a new study

Get alerted when new CEREBELLUM DYSPLASTIC GANGLIOCYTOMA trials appear

Sign up with your email to follow new studies for CEREBELLUM DYSPLASTIC GANGLIOCYTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

Could a cancer drug ease social struggles in rare genetic disorder?

Symptom relief Not yet recruiting

This study is testing if the drug everolimus can safely improve social skills in people with PTEN Hamartoma Tumor Syndrome (PHTS), a genetic condition often linked to autism-like social difficulties. For the first six months, half of the 60 participants will take everolimus pills…

Matched conditions: CEREBELLUM DYSPLASTIC GANGLIOCYTOMA

Phase: PHASE2, PHASE3 • Sponsor: Boston Children's Hospital • Aim: Symptom relief

Last updated Mar 31, 2026 12:12 UTC

CEREBELLUM DYSPLASTIC GANGLIOCYTOMA

Get alerted when new CEREBELLUM DYSPLASTIC GANGLIOCYTOMA trials appear

Could a cancer drug ease social struggles in rare genetic disorder?